Impact of Calcium Channel Blockers on Aspirin Reactivity in Patients with Coronary Artery Disease

被引：0
|
作者：
Afek Kodesh
Eli Lev
Dorit Leshem-Lev
Alejandro Solodky
Ran Kornowski
Leor Perl
机构：
[1] Beilinson Hospital,Cardiovascular Division, Rabin Medical Center
[2] Tel-Aviv University,The “Sackler” Faculty of Medicine
[3] Ben-Gurion University of the Negev,Department of Cardiology, Assuta Ashdod Medical Center and the Faculty of Health Sciences
[4] Rabin Medical Center,Felsenstein Medical Research Center
来源：
Cardiovascular Drugs and Therapy | 2022年 / 36卷
关键词：
Calcium channel blockers; High on-aspirin platelet reactivity; Coronary artery disease; Acute coronary syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：467 / 473
页数：6
相关论文
共 50 条
  • [1] Impact of Calcium Channel Blockers on Aspirin Reactivity in Patients with Coronary Artery Disease
    Kodesh, Afek
    Lev, Eli
    Leshem-Lev, Dorit
    Solodky, Alejandro
    Kornowski, Ran
    Perl, Leor
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 467 - 473
  • [2] Impact of combination of calcium-channel blockers with clopidogrel on clinical outcomes in patients with coronary artery disease
    Peng, Yong
    Chen, Mao
    Chai, Hua
    Liu, Xiao-jing
    Yan, Shao-di
    Li, Qiao
    Wei, Jia-fu
    Xu, Yuan-ning
    Wu, Wen-chao
    Huang, De-jia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 149 (02) : 274 - 276
  • [3] A review of stroke in patients with hypertension and coronary artery disease: focus on calcium channel blockers
    Bangalore, S.
    Messerli, F. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (10) : 1281 - 1286
  • [4] Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease
    Jose B. Cruz Rodriguez
    Haider Alkhateeb
    Current Cardiology Reports, 2020, 22
  • [5] Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease
    Cruz Rodriguez, Jose B.
    Alkhateeb, Haider
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (03)
  • [6] Aspirin Desensitization in Patients With Coronary Artery Disease Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease)
    Rossini, Roberta
    Iorio, Annamaria
    Pozzi, Roberto
    Bianco, Matteo
    Musumeci, Giuseppe
    Leonardi, Sergio
    Lettieri, Corrado
    Bossi, Irene
    Colombo, Paola
    Rigattieri, Stefano
    Dossena, Cinzia
    Anzuini, Angelo
    Capodanno, Davide
    Senni, Michele
    Angiolillo, Dominick J.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (02)
  • [7] Impact of Long-acting Calcium Channel Blockers on the Prognosis of Patients with Coronary Artery Disease With and Without Chronic Kidney Disease: a Comparison of Three Drugs
    Nitta, Y.
    Yamamoto, R.
    Yamaguchi, Y.
    Katsuda, S.
    Kaku, B.
    Taguchi, T.
    Takabatake, S.
    Nakahama, K.
    Yamagishi, M.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (01) : 253 - 265
  • [8] Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved?
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (05) : 831 - 834
  • [9] Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
    Zhang, J. W.
    Liu, W. W.
    McCaffrey, Timothy A.
    He, X. Q.
    Liang, W. Y.
    Chen, X. H.
    Feng, X. R.
    Fu, Sidney W.
    Liu, M. L.
    CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 1271 - 1279
  • [10] Aspirin in Patients with Coronary Artery Disease: Is it Simply Irresistible?
    Girish V. Nair
    Christopher J. Davis
    Marcus E. McKenzie
    David R. Lowry
    Victor L. Serebruany
    Journal of Thrombosis and Thrombolysis, 2001, 11 : 117 - 126
12345